曲阁
Lv5
970 积分
2022-01-23 加入
-
Evaluation of mechanical thrombectomy in acute ischemic stroke related to a distal arterial occlusion: A randomized controlled trial
3天前
已完结
-
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
1个月前
已完结
-
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
1个月前
已完结
-
Statin use and development and progression of non-alcohol fatty liver disease based on ultrasonography: a cohort study
1个月前
已关闭
-
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial
2个月前
已完结
-
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
2个月前
已完结
-
RhPro-UK in acute ischemic stroke within 4.5 hours of stroke onset trial-2(The PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial
2个月前
已完结
-
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
3个月前
已完结
-
RhPro-UK in acute ischemic stroke within 4.5 hours of stroke onset trial-2(The PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial
3个月前
已完结
-
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
4个月前
已完结